Oucomes of Endovascular Atherectomy in Femoropopliteal Arterial Disease

计划入组 60 人 · 首次发布于 2025 年 11 月 20 日

DCB Outcomes After Non-Compliant Balloon Vessel Preparation With or Without Scoring in Patients With Femoropopliteal Arterial Disease

计划入组 142 人 · 首次发布于 2026 年 8 月 13 日

DCB Outcomes After Plain or Scoring Balloon for Vessel Preparation in Patients With Femoropopliteal Arterial Disease

计划入组 83 人 · 首次发布于 2025 年 8 月 22 日

bioengineered human acellular vessel (peripheral arterial disease)

Peripheral arterial disease cell therapy (MultiGene Vascular Systems)

liver disease program

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

CURE RARE DISEASE, INC.

United States

SurVeil DCB Shows Comparable Efficacy to IN.PACT Admiral with 75% Lower Paclitaxel Dose in TRANSCEND Trial

SIRONA Trial: Sirolimus-Coated Balloons Show Non-Inferiority to Paclitaxel for Femoropopliteal Artery Disease

VIVA24: Late-Breaking Trials Highlight Advances in Vascular Intervention